NCT06993636View on ClinicalTrials.gov

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Kawasaki DiseaseCoronary Artery AneurysmRivaroxabanAnticoagulant DrugsPharmacokinetics and Pharmacodynamics
Trial Locations (1)

201102

RECRUITING

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER